Advertisement
Australia markets close in 5 hours 8 minutes
  • ALL ORDS

    7,969.00
    +31.10 (+0.39%)
     
  • ASX 200

    7,714.60
    +31.10 (+0.40%)
     
  • AUD/USD

    0.6496
    +0.0007 (+0.11%)
     
  • OIL

    83.45
    +0.09 (+0.11%)
     
  • GOLD

    2,334.80
    -7.30 (-0.31%)
     
  • Bitcoin AUD

    102,784.58
    -551.60 (-0.53%)
     
  • CMC Crypto 200

    1,435.37
    +20.61 (+1.46%)
     
  • AUD/EUR

    0.6062
    +0.0006 (+0.10%)
     
  • AUD/NZD

    1.0927
    -0.0003 (-0.03%)
     
  • NZX 50

    11,848.57
    +45.29 (+0.38%)
     
  • NASDAQ

    17,471.47
    +260.59 (+1.51%)
     
  • FTSE

    8,044.81
    +20.94 (+0.26%)
     
  • Dow Jones

    38,503.69
    +263.71 (+0.69%)
     
  • DAX

    18,137.65
    +276.85 (+1.55%)
     
  • Hang Seng

    16,828.93
    +317.24 (+1.92%)
     
  • NIKKEI 225

    38,244.30
    +692.14 (+1.84%)
     

Why Shares of Anavex Life Sciences Slumped 23.5% on Monday

Why Shares of Anavex Life Sciences Slumped 23.5% on Monday

What happened Shares of Anavex Life Sciences (NASDAQ: AVXL), a clinical-stage biotech that specializes in therapies to treat neurodegenerative and neurodevelopmental diseases, fell by 23.5% on Monday.